Home > Financial Ratios > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
EV/Core EBITDA

    Back to All Ratios
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.5119.2419.0315.1011.32

What is the latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES is 26.51 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202426.51
Mar202319.24
Mar202219.03
Mar202115.10
Mar202011.32

How is EV/Core EBITDA of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years EV/Core EBITDA % Change
Mar2024 26.51
37.79
Mar2023 19.24
1.10
Mar2022 19.03
26.03
Mar2021 15.1
33.39
Mar2020 11.32 -

Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES


Compare EV/Core EBITDA ratio of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹405,169.8 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics
MANKIND PHARMA ₹98,309.9 Cr 1.1% -7% 9.7% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-0.3%

-2.9%

11.5%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses